<DOC>
	<DOCNO>NCT01262118</DOCNO>
	<brief_summary>The purpose study explore effect CP-690,550 ( tasocitinib ) cholesterol metabolism patient active rheumatoid arthritis ( RA ) .</brief_summary>
	<brief_title>Effects Of CP-690,550 ( Tasocitinib ) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Males female , 18 year age older active rheumatoid arthritis ; Or male female healthy volunteer 18 year age old Pregnant lactate woman Clinically significant systemic disease ( RA RA arm ) Use lipidregulating agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Cholesterol metabolism</keyword>
	<keyword>Cholesterol flux</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Tasocitinib</keyword>
	<keyword>CP-690</keyword>
	<keyword>550</keyword>
</DOC>